Wang L - Search Results

1

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.

Liu YY, Leboeuf C, Shi JY, Li JM, Wang L, Shen Y, Garcia JF, Shen ZX, Chen Z, Janin A, Chen SJ, Zhao WL. Liu YY, et al. Among authors: wang l. Blood. 2007 Jul 1;110(1):339-44. doi: 10.1182/blood-2006-09-049189. Epub 2007 Mar 22. Blood. 2007. PMID: 17379744 Free article.

2

[Expression of tumor suppressor gene PRDM1 in lung cancers].

Liu YY, Yang SJ, Ma J, Wang L, Liu YH, Chen SJ, Shen ZX, Zhao WL. Liu YY, et al. Among authors: wang l. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):434-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974277 Chinese.

3

PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.

Zhao WL, Liu YY, Zhang QL, Wang L, Leboeuf C, Zhang YW, Ma J, Garcia JF, Song YP, Li JM, Shen ZX, Chen Z, Janin A, Chen SJ. Zhao WL, et al. Among authors: wang l. Blood. 2008 Apr 1;111(7):3867-71. doi: 10.1182/blood-2007-08-108654. Epub 2008 Jan 30. Blood. 2008. PMID: 18235046 Free article.

4

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL. Xu PP, et al. Among authors: wang l, wang y. Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710236

5

Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication.

Huo YJ, Xu PP, Fu D, Yi HM, Huang YH, Wang L, Wang N, Ji MM, Liu QX, Shi Q, Wang S, Cheng S, Feng Y, Zhao WL. Huo YJ, et al. Among authors: wang l, wang n, wang s. Blood Cancer J. 2022 Mar 29;12(3):48. doi: 10.1038/s41408-022-00644-2. Blood Cancer J. 2022. PMID: 35351868 Free PMC article. No abstract available.

6

Pretreatment Liver Injury Predicts Poor Prognosis of DLBCL Patients.

Shi Q, Shen R, Wang CF, Fan X, Qian Y, Ou-Yang BS, Zhao Y, Leboeuf C, Janin A, Cheng S, Wang L, Zhao WL. Shi Q, et al. Among authors: wang l, wang cf. Mediators Inflamm. 2017;2017:7960907. doi: 10.1155/2017/7960907. Epub 2017 Sep 17. Mediators Inflamm. 2017. PMID: 29109622 Free PMC article.

7

[Analysis of overexpression of vascular endothelial growth factor-C in patients with angioimmunoblastic T-cell lymphoma].

Zhao WL, Liu YY, Plassa F, Jin XL, Wang L, Janin A, Shen ZX. Zhao WL, et al. Among authors: wang l. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):664-6. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399170 Chinese.

8

Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia/lymphoma.

Shi WY, Wang L, Xiao D, Yao Y, Yang F, Jiang XX, Leboeuf C, Janin A, Chen SJ, Zhao WL. Shi WY, et al. Among authors: wang l. Ann Hematol. 2011 Jan;90(1):53-8. doi: 10.1007/s00277-010-1022-1. Epub 2010 Jul 9. Ann Hematol. 2011. PMID: 20617436

9

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.

Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A. Wang L, et al. Among authors: wang ah. J Hematol Oncol. 2010 Sep 9;3:30. doi: 10.1186/1756-8722-3-30. J Hematol Oncol. 2010. PMID: 20828385 Free PMC article.

10

Bevacizumab potentiates chemotherapeutic effect on T-leukemia/lymphoma cells by direct action on tumor endothelial cells.

Wang L, Shi WY, Yang F, Tang W, Gapihan G, Varna M, Shen ZX, Chen SJ, Leboeuf C, Janin A, Zhao WL. Wang L, et al. Haematologica. 2011 Jun;96(6):927-31. doi: 10.3324/haematol.2010.037689. Epub 2011 Feb 17. Haematologica. 2011. PMID: 21330328 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146,398 results

Search Page

Filters